These cells strongly respond to the well-known hormone receptor drug agonists Semaglutide, Orforglipron, Tirzepatide, and Retatrutide (see figures)
Do I understand the difference between FDA-approved and compounded medications
Bubble or Behavioral Reset
Tirzepatide and semaglutide are both incretin-based medications that lower blood sugar and promote weight loss, but they work through different pathwayssemaglutide targets the GLP-1 receptor alone, while tirzepatide activates both GLP-1 and GIP receptors
The mechanism of action has been determined that KPV inhibits the activation of NF-kappaB and MAP kinase inflammatory signaling pathways, and reduces pro-inflammatory cytokine secretionacts via PepT1 expressed in immune and intestinal epithelial cells..[and] reduces the incidence of DSS- and TNBS-induced colitis indicated by a decrease in pro-inflammatory cytokine expression (Dalmasso et al., 2008)
Because both the safety and the effectiveness of BPC-157 in humans are unknown, the peptide cannot be labeled as more effective for recovery than HGH